EX-23

             REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Shareholders and Board of Trustees of
Oppenheimer Series Fund, Inc.

In planning and performing our audit of the financial statements of Oppenheimer
Value Fund (a portfolio of the Oppenheimer Series Fund, Inc.) (the "Fund") as of
and for the year ended October 31, 2007, in accordance with the standards of the
Public Company Accounting Oversight Board (United States), we considered the
Fund's internal control over financial reporting, including controls over
safeguarding securities, as a basis for designing our auditing procedures for
the purpose of expressing our opinion on the financial statements and to comply
with the requirements of Form N-SAR, but not for the purpose of expressing an
opinion on the effectiveness of the Fund's internal control over financial
reporting. Accordingly, we express no such opinion.

Management of the Fund is responsible for establishing and maintaining effective
internal control over financial reporting. In fulfilling this responsibility,
estimates and judgments by management are required to assess the expected
benefits and related costs of controls. A company's internal control over
financial reporting is a process designed to provide reasonable assurance
regarding the reliability of financial reporting and the preparation of
financial statements for external purposes in accordance with generally accepted
accounting principles. A company's internal control over financial reporting
includes those policies and procedures that (1) pertain to the maintenance of
records that, in reasonable detail, accurately and fairly reflect the
transactions and dispositions of the assets of the company; (2) provide
reasonable assurance that transactions are recorded as necessary to permit
preparation of financial statements in accordance with generally accepted
accounting principles, and that receipts and expenditures of the company are
being made only in accordance with authorizations of management and directors of
the company; and (3) provide reasonable assurance regarding prevention or timely
detection of unauthorized acquisition, use, or disposition of the company's
assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting
may not prevent or detect misstatements. Also, projections of any evaluation of
effectiveness to future periods are subject to the risk that controls may become
inadequate because of changes in conditions, or that the degree of compliance
with the policies or procedures may deteriorate.

A deficiency in internal control over financial reporting exists when the design
or operation of a control does not allow management or employees, in the normal
course of performing their assigned functions, to prevent or detect
misstatements on a timely basis. A material weakness is a deficiency, or a
combination of deficiencies, in internal control over financial reporting, such
that there is a reasonable possibility that a material misstatement of the
Fund's annual or interim financial statements will not be prevented or detected
on a timely basis.

Our consideration of the Fund's internal control over financial reporting was
for the limited purpose described in the first paragraph and would not
necessarily disclose all deficiencies in internal control that might be
deficiencies or material weaknesses under standards established by the Public
Company Accounting Oversight Board (placecountry-regionUnited States). However,
we noted no deficiencies in the Fund's internal control over financial reporting
and its operation, including controls for safeguarding securities, that we
consider to be a material weakness as defined above as of October 31, 2007.

This report is intended solely for the information and use of management and the
Board of Trustees of Oppenheimer Series Fund, Inc. and the Securities and
Exchange Commission and is not intended to be and should not be used by anyone
other than these specified parties.




                                    KPMG LLP

Denver, Colorado
December 13, 2007

EX-99

Net investment income (loss) and net realized gain (loss) may differ for
financial statement and tax purposes. The character of dividends and
distributions made during the fiscal year from net investment income or net
realized gains may differ from their ultimate characterization for federal
income tax purposes. Also, due to timing of dividends and distributions, the
fiscal year in which amounts are distributed may differ from the fiscal year in
which the income or net realized gain was recorded by the Fund. Accordingly, the
following amounts have been reclassified for October 31, 2007. Net assets of the
Fund were unaffected by the reclassifications.
                                                        REDUCTION TO
                                  INCREASE TO        ACCUMULATED NET
          INCREASE TO         ACCUMULATED NET       REALIZED GAIN ON
          PAID-IN CAPITAL   INVESTMENT INCOME          INVESTMENTS 4
          -----------------------------------------------------------
              $33,578,013                $441            $33,578,454

4. $33,133,621, including $22,961,291 of long-term capital gain, was distributed
in connection with Fund share redemptions.

EX-99.77Q1 OTHR EXHB

Oppenheimer Value Fund
Period Ending 10-31-07
Exhibit 77Q1

                          OPPENHEIMER SERIES FUND, INC.
                              ARTICLE SUPPLEMENTARY

         Oppenheimer Series Fund, Inc., a Maryland corporation, having its
principal office in Baltimore City, Maryland (hereinafter called the
"Corporation"), hereby certifies to the State Department of Assessments and
Taxation of Maryland that:

         FIRST: The Corporation is registered as an open-end company under the
Investment Company Act of 1940, as amended, with the authority to issue
3,000,000,000 (Three Billion) shares of capital stock, par value $0.001 per
share and aggregate par value $3,000,000, classified as follows:

         SERIES AND CLASSES                                    AUTHORIZED SHARES

         Oppenheimer Disciplined Allocation Fund
              Class A Common Stock                                   300,000,000
              Class B Common Stock                                   100,000,000
              Class C Common Stock                                    50,000,000
              Class N Common Stock                                   100,000,000
              Class Y Common Stock                                    50,000,000

         Oppenheimer Value Fund
              Class A Common Stock                                   300,000,000
              Class B Common Stock                                   100,000,000
              Class C Common Stock                                    50,000,000
              Class N Common Stock                                   100,000,000
              Class Y Common Stock                                    50,000,000

The remaining 1,850,000,000 shares of common stock of the Corporation were
undesignated as to series or class.

         SECOND: There are no shares of the Oppenheimer Disciplined Allocation
Fund series currently outstanding.

         THIRD: The Board of Directors hereby reclassifies as Class Y shares of
Oppenheimer Value Fund 50,000,000 shares of common stock that were previously
undesignated as to series or class and reclassifies all of the Class A, Class B,
Class C, Class N and Class Y shares of common stock of Oppenheimer Disciplined
Allocation Fund as being undesignated as to series or class.

         FOURTH: After this reclassification, the total number of shares of all
classes and series of stock which the Corporation has authority to issue remains
3,000,000,000 (Three Billion) shares of capital stock, par value $0.001 per
share and aggregate par value $3,000,000, and is, classified and designated as
follows.

         SERIES AND CLASSES                                    AUTHORIZED SHARES

         Oppenheimer Value Fund
              Class A Common Stock                                   300,000,000
              Class B Common Stock                                   100,000,000
              Class C Common Stock                                    50,000,000
              Class N Common Stock                                   100,000,000
              Class Y Common Stock                                   100,000,000

The remaining 2,350,000,000 shares of common stock of the Corporation are
undesignated as to series or class.

         FIFTH: The forgoing does not change the preferences, conversion or
other rights, voting powers, restrictions, limitations as to dividends,
qualifications, or terms or conditions of redemption, as set forth in the
Articles of Incorporation, of the Capital Stock of the Corporation existing
before the reclassification. The terms of the reclassified Class Y shares of the
Oppenheimer Value Fund (including the preferences, conversion or other rights,
voting powers, restrictions, limitations as to dividends and other
distributions, qualifications, or terms or conditions of redemption) shall be as
set forth in the Articles of Incorporation for the Capital Stock of the
Corporation existing before the reclassification.

         SIXTH: The foregoing reclassification has been approved by a majority
of the entire Board of Directors pursuant to authority expressly granted to the
Board of Directors by Sections 2-105(a)(9), and 2-605(a)(2) of the Maryland
General Corporation Law, and in Article FOURTH of the Charter of the
Corporation.

         SEVENTH: The foregoing articles shall become effective upon filing with
the State Department of Assessments and Taxation of Maryland.

         IN WITNESS WHEREOF, OPPENHEIMER VALUE FUND, INC., has caused these
presents to be signed in its name and on its behalf by its Vice President and
witnessed by its Assistant Secretary on December 7, 2007.


WITNESS:                                            OPPENHEIMER VALUE FUND, INC.


/s/ Phillip S. Gillespie                       By:      /s/ Mark Vandehey
- -----------------------------------------      ---------------------------------
Phillip S. Gillespie, Assistant Secretary      Mark Vandehey, Vice President



         THE UNDERSIGNED, Vice President of OPPENHEIMER VALUE FUND, INC., who
executed on behalf of the Corporation the foregoing Articles Supplementary of
which this certificate is made a part, hereby acknowledges in the name and on
behalf of said Corporation the foregoing Articles Supplementary to be the
corporate act of said Corporation and hereby certifies that to the best of his
knowledge, information, and belief the matters and facts set forth therein with
respect to the authorization and approval thereof are true in all material
respects under the penalties of perjury.


                                                   /s/ Mark Vandehey
                                                   -----------------------------
                                                   Mark Vandehey, Vice President